Radiotherapy and Oncology




One-year access to more than 500 world journals available in the system
    http://medilib.ir
  • Duration of Time : 365 Day
  • Price : 300$
  • Special Price : 100$
Order
Journals package 3months
    http://medilib.ir
  • Duration of Time : 93 Day
  • Price : 100$
  • Special Price : 50$
Order

Aims+Scope/Editorial Board/ Publication information

doi : 10.1016/S0167-8140(25)04581-5

Volume 210, September 2025, 111077

Buy The Package and View The Article Online



Danish Head and Neck Cancer Group (DAHANCA) Radiotherapy Quality Assurance Guidelines 2025. Update and new chapters: Planning of complex targets, hypofractionation, planning of reirradiation, target definition after induction chemotherapy, and clarification of the guidelines for elective targets

doi : 10.1016/j.radonc.2025.111028

Buy The Package and View The Article Online


Shifting away from elective nodal irradiation in HNSCC: What do we know and Where are we heading?

doi : 10.1016/j.radonc.2025.111046

Buy The Package and View The Article Online


GEC-ESTRO guidelines for commissioning and quality assurance of TG-43 based brachytherapy treatment planning systems

doi : 10.1016/j.radonc.2025.111008

Buy The Package and View The Article Online


Understanding national Societies’ needs and enhancing collaboration with ESTRO: A report of the national Societies survey 2024, on behalf of the ESTRO national Societies committee

doi : 10.1016/j.radonc.2025.111006

Buy The Package and View The Article Online


Repositioning Radiation Oncology at the centre of integrated oncology care: A manifesto of the European Society for Radiotherapy and Oncology (ESTRO)

doi : 10.1016/j.radonc.2025.111035

Buy The Package and View The Article Online


Selection of patients for proton therapy to reduce risk of second primary lung and breast cancer

doi : 10.1016/j.radonc.2025.110998

Buy The Package and View The Article Online


The dynamic changes of glymphatic function at different post-radiotherapy stages in patients with nasopharyngeal carcinoma

doi : 10.1016/j.radonc.2025.111012

Buy The Package and View The Article Online


Non-cisplatin concurrent agents plus definitive radiotherapy for locally advanced head and neck cancer: A network meta-analysis of randomized studies

doi : 10.1016/j.radonc.2025.111033

Buy The Package and View The Article Online


Use of patient-derived tumor organoids from head and neck squamous cell carcinoma for the evaluation of the differential effect of carbon ions over X-rays

doi : 10.1016/j.radonc.2025.111026

Buy The Package and View The Article Online


Comparing adaptive and dose redistributed radiotherapy to conventional radiotherapy in head and neck cancer – Quality of life results from the phase III ARTFORCE trial

doi : 10.1016/j.radonc.2025.111044

Buy The Package and View The Article Online


Multimodal prognostic model for de novo metastatic nasopharyngeal carcinoma after first-line immunochemotherapy

doi : 10.1016/j.radonc.2025.111010

Buy The Package and View The Article Online


Unilateral vs bilateral neck irradiation: The importance of careful patient selection in tailoring radiation therapy for lateralized palatine-tonsil and non-palatine-tonsil oropharyngeal carcinoma

doi : 10.1016/j.radonc.2025.111049

Buy The Package and View The Article Online


CNG (Collaborative Nasopharyngeal Carcinoma Group) stage: Improved prognostic stratification of nasopharyngeal carcinoma and association with Epstein-Barr virus DNA in the intensity-modulated radiation therapy era

doi : 10.1016/j.radonc.2025.111051

Buy The Package and View The Article Online


Lymphocyte nadir and recovery dynamics for locally advanced thoracic malignancies undergoing concurrent chemo-irradiation: Establishment of organs-at-risk constraints

doi : 10.1016/j.radonc.2025.111009

Buy The Package and View The Article Online


oDigital pathology biomarkers for guiding radiotherapy-based treatment concepts in prostate cancer − a systematic review and expert consensus

doi : 10.1016/j.radonc.2025.111039

Buy The Package and View The Article Online


The role of stereotactic body radiotherapy in oligoprogressive prostate cancer: A site-specific analysis of the prospective, phase II RADIANT trial

doi : 10.1016/j.radonc.2025.111041

Buy The Package and View The Article Online


Evaluation of brachytherapy applicators and their association with morbidity and local control in cervix cancer: An EMBRACE I analysis

doi : 10.1016/j.radonc.2025.110954

Buy The Package and View The Article Online


Prospective evaluation of AI-based BiCycle autoplanning for advanced cervical cancer brachytherapy

doi : 10.1016/j.radonc.2025.111029

Buy The Package and View The Article Online


Predicting acute diarrhoea in rectal cancer chemoradiotherapy: Secondary analysis of the phase III ARISTOTLE trial

doi : 10.1016/j.radonc.2025.111032

Buy The Package and View The Article Online


Multiomic based Bayesian network toxicity modeling for simultaneous prediction of multiple toxicity outcomes in NSCLC

doi : 10.1016/j.radonc.2025.111011

Buy The Package and View The Article Online


Balancing the dose: A meta-analysis of preoperative radiotherapy strategies for soft tissue sarcomas

doi : 10.1016/j.radonc.2025.111034

Buy The Package and View The Article Online


Predicting the impact of target volume contouring variations on the organ at risk dose: results of a qualitative survey

doi : 10.1016/j.radonc.2025.110999

Buy The Package and View The Article Online


Improving risk assessment of local failure in brain metastases patients using vision transformers − A multicentric development and validation study

doi : 10.1016/j.radonc.2025.111031

Buy The Package and View The Article Online


Transfer of arrhythmia substrate targets from the cardiac electroanatomical and imaging modalities to the planning computed tomography scan for stereotactic arrhythmia radioablation for refractory ventricular tachycardia – a state-of-the-art review on software developments on behalf of the STOPSTORM.eu consortium

doi : 10.1016/j.radonc.2025.111004

Buy The Package and View The Article Online


NTCP models based on CT-guided online adaptive SBRT for abdominal lymph node oligometastases

doi : 10.1016/j.radonc.2025.111027

Buy The Package and View The Article Online


Evaluation of the prognostic value of the ESTRO/EORTC classification of reirradiation in patients with non-small cell lung cancer☆

doi : 10.1016/j.radonc.2025.111003

Buy The Package and View The Article Online


Reirradiation dose constraints in clinical practice: Results of an international survey☆

doi : 10.1016/j.radonc.2025.111030

Buy The Package and View The Article Online


Salvage brachytherapy for recurrent prostate cancer after radiotherapy: An expert-endorsed review by uroGEC

doi : 10.1016/j.radonc.2025.111042

Buy The Package and View The Article Online


Commentary on “Further data to enhance clinical integration of nodal hypofractionation: A commentary on the FAST-Forward nodal sub-study�

doi : 10.1016/j.radonc.2025.111037

Buy The Package and View The Article Online


Further Data to Support Clinical Integration of Nodal Hypofractionation: A Commentary on the FAST-Forward Nodal Sub-study

doi : 10.1016/j.radonc.2025.111036

Buy The Package and View The Article Online


Reappraising OPTIMAL-HN: Pragmatic progress or premature pivot in RIM pain management?

doi : 10.1016/j.radonc.2025.111005

Buy The Package and View The Article Online


Response to “Reappraising OPTIMAL-HN: pragmatic progress or premature pivot in RIM pain management?�

doi : 10.1016/j.radonc.2025.111007

Buy The Package and View The Article Online


Do you want to add Medilib to your home screen?